Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases
GS Hazlewood, JP Pardo, C Barnabe… - The Journal of …, 2021 - jrheum.org
Objective To develop guidance on the use of coronavirus disease 2019 (COVID-19)
vaccines in patients with autoimmune rheumatic diseases (ARD). Methods The Canadian …
vaccines in patients with autoimmune rheumatic diseases (ARD). Methods The Canadian …
[HTML][HTML] COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey
P Gaur, H Agrawat, A Shukla - Rheumatology international, 2021 - Springer
Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-
2 infection. Vaccination against this infection can prevent the patients from developing …
2 infection. Vaccination against this infection can prevent the patients from developing …
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic …
LM Frommert, ANA de Silva, J Zernicke, V Scholz… - RMD open, 2022 - rmdopen.bmj.com
Objective The development of sufficient COVID-19 vaccines has been a big breakthrough in
fighting the global SARS-CoV-2 pandemic. However, vaccination effectiveness can be …
fighting the global SARS-CoV-2 pandemic. However, vaccination effectiveness can be …
Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey
C Campochiaro, G Trignani, A Tomelleri… - Annals of the …, 2021 - ard.bmj.com
Similarly to the general population, advanced age, comorbidities and chronic glucocorticoid
treatment (≥ 10 mg/day prednisoneequivalent) have been identified as negative prognostic …
treatment (≥ 10 mg/day prednisoneequivalent) have been identified as negative prognostic …
[HTML][HTML] COVID-19 vaccination in immunocompromised patients
Almost 1 year into the coronavirus disease 2019 (COVID-19) pandemic, and after more than
50 million cases and 1.35 million deaths globally, reports of the successful conclusion of …
50 million cases and 1.35 million deaths globally, reports of the successful conclusion of …
[HTML][HTML] Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis
Background: Vaccination is one of the most important measures worldwide to halt the
spread of the corona virus disease 2019 (COVID-19). However, the efficacy and safety of …
spread of the corona virus disease 2019 (COVID-19). However, the efficacy and safety of …
[HTML][HTML] The use of COVID-19 vaccines in patients with SLE
W Tang, Y Gartshteyn, E Ricker, S Inzerillo… - Current rheumatology …, 2021 - Springer
Abstract Purpose of Review Three COVID-19 vaccines obtained emergency authorization
from the Food and Drug Administration (FDA) and are widely used in the USA …
from the Food and Drug Administration (FDA) and are widely used in the USA …
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general …
V Furer, T Eviatar, D Zisman, H Peleg… - Annals of the …, 2021 - ard.bmj.com
Introduction Vaccination represents a cornerstone in mastering the COVID-19 pandemic.
Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with …
Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with …
[HTML][HTML] Preliminary data on post market safety profiles of COVID 19 vaccines in rheumatic diseases: assessments on various vaccines in use, different rheumatic …
C Rotondo, FP Cantatore, M Fornaro, R Colia, G Busto… - Vaccines, 2021 - mdpi.com
An increased risk of developing severe infections has been evidenced in rheumatic disease
(RD) patients, and anti-COVID-19 vaccination is strictly recommended for RD patients …
(RD) patients, and anti-COVID-19 vaccination is strictly recommended for RD patients …
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician …
PM Machado, S Lawson-Tovey, A Strangfeld… - Annals of the …, 2022 - ard.bmj.com
Objectives To describe the safety of vaccines against SARS-CoV-2 in people with
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods …
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods …